Income Taxes - Schedule of Deferred Income Taxes Reflect the Net Tax Effects of Temporary Differences (Details) - USD ($) |
Sep. 30, 2025 |
Sep. 30, 2024 |
|---|---|---|
| Deferred tax assets: | ||
| Net operating loss carryforward | $ 12,720,000 | $ 7,530,000 |
| Capitalized research and development expense | 3,189,000 | 2,080,000 |
| Stock-based compensation | 1,928,000 | 1,091,000 |
| Research tax credit | 1,581,000 | 1,035,000 |
| Valuation allowance on deferred tax assets | (19,418,000) | (11,736,000) |
| Total deferred tax assets | ||
| Deferred tax liabilities: | ||
| In-process research and development | (2,784,960) | (1,728,000) |
| Total deferred tax liability | (2,784,960) | (1,728,000) |
| Net deferred tax liability | $ (2,784,960) | $ (1,728,000) |
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences from research and development costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|